Agile Therapeutics, Inc. Operating Lease Right-of-Use Assets
Agile Therapeutics, Inc. had Operating Lease Right-of-Use Assets of $255.00 thousand as of 2024-06-30, per its 10-Q filed 2024-08-12.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2024-08-12
- 2024-06-30: Operating Lease, Right-of-Use Asset $255.00K.
- 2024-03-31: Operating Lease, Right-of-Use Asset $335.00K.
- 2023-12-31: Operating Lease, Right-of-Use Asset $412.00K.
- 2023-09-30: Operating Lease, Right-of-Use Asset $486.00K.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2024-06-30 | $255.00K 10-Q · filed 2024-08-12 |
| 2024-03-31 | $335.00K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $412.00K 10-Q · filed 2024-08-12 |
| 2023-09-30 | $486.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $558.00K 10-Q · filed 2023-08-09 |
| 2023-03-31 | $628.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $695.00K 10-K · filed 2024-03-28 |
| 2022-09-30 | $761.00K 10-K · filed 2023-03-23 |
| 2022-06-30 | $825.00K 10-K · filed 2023-03-23 |
| 2022-03-31 | $888.00K 10-K · filed 2023-03-23 |
| 2021-12-31 | $949.00K 10-K · filed 2023-03-23 |
| 2021-09-30 | $37.00K 10-Q/A · filed 2021-12-30 |
| 2021-06-30 | $72.00K 10-Q · filed 2021-07-26 |
| 2021-03-31 | $106.00K 10-Q · filed 2021-05-04 |
| 2020-12-31 | $138.00K 10-K · filed 2022-03-30 |
| 2020-09-30 | $31.00K 10-Q · filed 2020-11-12 |
| 2019-12-31 | $158.00K 10-K · filed 2021-03-01 |
| 2019-09-30 | $214.00K 10-Q · filed 2019-10-28 |
| 2019-06-30 | $250.00K 10-Q · filed 2019-08-01 |
| 2019-03-31 | $284.00K 10-Q · filed 2019-05-03 |
| 2018-12-31 | $18.00K 10-Q · filed 2019-10-28 |